{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:20:05Z","timestamp":1794345605959,"version":"4.9.0"},"publisher-location":"Boston, MA","reference-count":139,"publisher":"Springer US","isbn-type":[{"value":"9780387468044","type":"print"},{"value":"9780387468167","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007]]},"DOI":"10.1007\/978-0-387-46816-7_5","type":"book-chapter","created":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T12:56:05Z","timestamp":1178196965000},"page":"141-162","source":"Crossref","is-referenced-by-count":17,"title":["Molecular Biology of EBV in Relationship to AIDS-Associated Oncogenesis"],"prefix":"10.1007","author":[{"given":"Bharat G.","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanao","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erle S.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5_CR1","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.64.5.2126-2134.1990","volume":"64","author":"S. D. Abbot","year":"1990","unstructured":"Abbot, S. D., M. Rowe, K. Cadwallader, A. Ricksten, J. Gordon, et al. 1990. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. J Virol 64:2126\u201334.","journal-title":"J Virol"},{"key":"5_CR2","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/JVI.61.5.1743-1746.1987","volume":"61","author":"A. Adams","year":"1987","unstructured":"Adams, A. 1987. Replication of latent Epstein-Barr virus genomes in Raji cells. J Virol 61:1743\u20136.","journal-title":"J Virol"},{"key":"5_CR3","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1128\/JVI.79.7.4415-4424.2005","volume":"79","author":"N. Ahsan","year":"2005","unstructured":"Ahsan, N., T. Kanda, K. Nagashima, and K. Takada. 2005. Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. J Virol 79:4415\u201324.","journal-title":"J Virol"},{"issue":"7","key":"5_CR4","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1099\/0022-1317-70-7-1755","volume":"70","author":"M. J. Allday","year":"1989","unstructured":"Allday, M. J., D. H. Crawford, and B. E. Griffin. 1989. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J Gen Virol 70(Pt 7):1755\u201364.","journal-title":"J Gen Virol"},{"key":"5_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.456","volume":"15","author":"W. Amon","year":"2005","unstructured":"Amon, W., and P. J. Farrell. 2005. Reactivation of Epstein-Barr virus from latency. Rev Med Virol 15:149\u201356.","journal-title":"Rev Med Virol"},{"key":"5_CR6","doi-asserted-by":"crossref","first-page":"23491","DOI":"10.1074\/jbc.M002052200","volume":"275","author":"S. Aviel","year":"2000","unstructured":"Aviel, S., G. Winberg, M. Massucci, and A. Ciechanover. 2000. Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue. J Biol Chem 275:23491\u20139.","journal-title":"J Biol Chem"},{"key":"5_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/310207a0","volume":"310","author":"R. Baer","year":"1984","unstructured":"Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, et al. 1984. DNA sequence and expression of the B95\u20138 Epstein-Barr virus genome. Nature 310:207\u201311.","journal-title":"Nature"},{"key":"5_CR8","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1128\/JVI.61.10.3120-3132.1987","volume":"61","author":"M. Biggin","year":"1987","unstructured":"Biggin, M., M. Bodescot, M. Perricaudet, and P. Farrell. 1987. Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. J Virol 61:3120\u201332.","journal-title":"J Virol"},{"key":"5_CR9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1074-7613(00)80397-0","volume":"7","author":"N. Blake","year":"1997","unstructured":"Blake, N., S. Lee, I. Redchenko, W. Thomas, N. Steven, et al. 1997. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 7:791\u2013802.","journal-title":"Immunity"},{"key":"5_CR10","first-page":"4620","volume":"56","author":"S. N. Boyer","year":"1996","unstructured":"Boyer, S. N., D. E. Wazer, and V. Band. 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56:4620\u20134.","journal-title":"Cancer Res"},{"key":"5_CR11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1084\/jem.193.8.943","volume":"193","author":"K. D. Brown","year":"2001","unstructured":"Brown, K. D., B. S. Hostager, and G. A. Bishop. 2001. Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 193:943\u201354.","journal-title":"J Exp Med"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","volume":"46","author":"D. Burkitt","year":"1958","unstructured":"Burkitt, D. 1958. A sarcoma involving the jaws in African children. Br J Surg 46:218\u201323.","journal-title":"Br J Surg"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1128\/JVI.66.5.3257-3262.1992","volume":"66","author":"P. Busson","year":"1992","unstructured":"Busson, P., R. McCoy, R. Sadler, K. Gilligan, T. Tursz, and N. Raab-Traub. 1992. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol 66:3257\u201362.","journal-title":"J Virol"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1371\/journal.ppat.0020023","volume":"2","author":"X. Cai","year":"2006","unstructured":"Cai, X., A. Schafer, S. Lu, J. P. Bilello, R. C. Desrosiers, et al. 2006. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2:e23.","journal-title":"PLoS Pathog"},{"key":"5_CR15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0168-1702(94)90073-6","volume":"31","author":"H. Cen","year":"1994","unstructured":"Cen, H., and J. L. McKnight. 1994. EBV-immortalized isogenic human B-cell clones exhibit differences in DNA-protein complex formation on the BZLF1 and BRLF1 promoter regions among latent, lytic and TPA-activated cell lines. Virus Res 31:89\u2013107.","journal-title":"Virus Res"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1073\/pnas.0408381102","volume":"102","author":"F. Cerimele","year":"2005","unstructured":"Cerimele, F., T. Battle, R. Lynch, D. A. Frank, E. Murad, et al. 2005. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc Natl Acad Sci USA 102:175\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR17","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.1073\/pnas.181347998","volume":"98","author":"B. Chaudhuri","year":"2001","unstructured":"Chaudhuri, B., H. Xu, I. Todorov, A. Dutta, and J. L. Yates. 2001. Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc Natl Acad Sci USA 98:10085\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR18","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1073\/pnas.86.23.9558","volume":"86","author":"J. I. Cohen","year":"1989","unstructured":"Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci USA 86:9558\u201362.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR19","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1073\/pnas.82.12.4085","volume":"82","author":"J. Countryman","year":"1985","unstructured":"Countryman, J., and G. Miller. 1985. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci USA 82:4085\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/JVI.64.1.313-321.1990","volume":"64","author":"M. A. Cox","year":"1990","unstructured":"Cox, M. A., J. Leahy, and J. M. Hardwick. 1990. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J Virol 64:313\u201321.","journal-title":"J Virol"},{"key":"5_CR21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1097-2765(02)00476-8","volume":"9","author":"Z. Deng","year":"2002","unstructured":"Deng, Z., L. Lezina, C. J. Chen, S. Shtivelband, W. So, and P. M. Lieberman. 2002. Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication. Mol Cell 9:493\u2013503.","journal-title":"Mol Cell"},{"key":"5_CR22","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1128\/MCB.16.12.7098","volume":"16","author":"O. Devergne","year":"1996","unstructured":"Devergne, O., E. Hatzivassiliou, K. M. Izumi, K. M. Kaye, M. F. Kleijnen, et al. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-kappaB activation. Mol Cell Biol 16:7098\u2013108.","journal-title":"Mol Cell Biol"},{"key":"5_CR23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0092-8674(01)00458-5","volume":"106","author":"S. K. Dhar","year":"2001","unstructured":"Dhar, S. K., K. Yoshida, Y. Machida, P. Khaira, B. Chaudhuri, et al. 2001. Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell 106:287\u201396.","journal-title":"Cell"},{"key":"5_CR24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4049\/jimmunol.165.2.663","volume":"165","author":"D. F. Dukers","year":"2000","unstructured":"Dukers, D. F., P. Meij, M. B. Vervoort, W. Vos, R. J. Scheper, et al. 2000. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J Immunol 165:663\u201370.","journal-title":"J Immunol"},{"key":"5_CR25","first-page":"2243","volume":"13","author":"A. G. Eliopoulos","year":"1996","unstructured":"Eliopoulos, A. G., C. W. Dawson, G. Mosialos, J. E. Floettmann, M. Rowe, et al. 1996. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: Involvement of TRAF3 as a common mediator. Oncogene 13:2243\u201354.","journal-title":"Oncogene"},{"key":"5_CR26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"15","author":"M. A. Epstein","year":"1964","unstructured":"Epstein, M. A., B. G. Achong, and Y. M. Barr. 1964. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 15:702\u20133.","journal-title":"Lancet"},{"key":"5_CR27","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1073\/pnas.87.19.7390","volume":"87","author":"R. Fahraeus","year":"1990","unstructured":"Fahraeus, R., A. Jansson, A. Ricksten, A. Sjoblom, and L. Rymo. 1990. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc Natl Acad Sci USA 87:7390\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0753-3322(97)83541-X","volume":"51","author":"P. J. Farrell","year":"1997","unstructured":"Farrell, P. J., I. Cludts, and A. Stuhler. 1997. Epstein-Barr virus genes and cancer cells. Biomed Pharmacother 51:258\u201367.","journal-title":"Biomed Pharmacother"},{"key":"5_CR29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0966-842X(00)01742-X","volume":"8","author":"G. C. Faulkner","year":"2000","unstructured":"Faulkner, G. C., A. S. Krajewski, and D. H. Crawford. 2000. The ins and outs of EBV infection. Trends Microbiol 8:185\u20139.","journal-title":"Trends Microbiol"},{"key":"5_CR30","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1128\/JVI.66.3.1786-1790.1992","volume":"66","author":"L. Frappier","year":"1992","unstructured":"Frappier, L., and M. O'Donnell. 1992. EBNA1 distorts oriP, the Epstein-Barr virus latent replication origin. J Virol 66:1786\u201390.","journal-title":"J Virol"},{"key":"5_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/viro.1997.8690","volume":"235","author":"S. Fruehling","year":"1997","unstructured":"Fruehling, S., and R. Longnecker. 1997. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235:241\u201351.","journal-title":"Virology"},{"key":"5_CR32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(72)92402-6","volume":"2","author":"P. Gerber","year":"1972","unstructured":"Gerber, P., S. Lucas, M. Nonoyama, E. Perlin, and L. I. Goldstein. 1972. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet 2:988\u20139.","journal-title":"Lancet"},{"key":"5_CR33","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1128\/JVI.64.10.4948-4956.1990","volume":"64","author":"K. Gilligan","year":"1990","unstructured":"Gilligan, K., H. Sato, P. Rajadurai, P. Busson, L. Young, et al. 1990. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol 64:4948\u201356.","journal-title":"J Virol"},{"key":"5_CR34","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1093\/emboj\/18.11.3064","volume":"18","author":"O. Gires","year":"1999","unstructured":"Gires, O., F. Kohlhuber, E. Kilger, M. Baumann, A. Kieser, et al. 1999. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. Embo J 18:3064\u201373.","journal-title":"Embo J"},{"key":"5_CR35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/340393a0","volume":"340","author":"W. Hammerschmidt","year":"1989","unstructured":"Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340:393\u20137.","journal-title":"Nature"},{"key":"5_CR36","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1128\/MCB.22.7.2136-2146.2002","volume":"22","author":"I. Han","year":"2002","unstructured":"Han, I., Y. Xue, S. Harada, S. Orstavik, B. Skalhegg, and E. Kieff. 2002. Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins. Mol Cell Biol 22:2136\u201346.","journal-title":"Mol Cell Biol"},{"key":"5_CR37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.8016657","volume":"265","author":"T. Henkel","year":"1994","unstructured":"Henkel, T., P. D. Ling, S. D. Hayward, and M. G. Peterson. 1994. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science 265:92\u20135.","journal-title":"Science"},{"key":"5_CR38","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.157.3792.1064","volume":"157","author":"W. Henle","year":"1967","unstructured":"Henle, W., V. Diehl, G. Kohn, H. Zur Hausen, and G. Henle. 1967. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157:1064\u20135.","journal-title":"Science"},{"key":"5_CR39","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1128\/JVI.73.4.2770-2780.1999","volume":"73","author":"H. Hofelmayr","year":"1999","unstructured":"Hofelmayr, H., L. J. Strobl, C. Stein, G. Laux, G. Marschall, et al. 1999. Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters. J Virol 73:2770\u201380.","journal-title":"J Virol"},{"key":"5_CR40","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1073\/pnas.83.23.9006","volume":"83","author":"J. G. Howe","year":"1986","unstructured":"Howe, J. G., and J. A. Steitz. 1986. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci USA 83:9006\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1128\/JVI.53.2.528-535.1985","volume":"53","author":"G. S. Hudson","year":"1985","unstructured":"Hudson, G. S., P. J. Farrell, and B. G. Barrell. 1985. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95\u20138. J Virol 53:528\u201335.","journal-title":"J Virol"},{"key":"5_CR42","first-page":"549","volume":"10","author":"D. S. Huen","year":"1995","unstructured":"Huen, D. S., S. A. Henderson, D. Croom-Carter, and M. Rowe. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549\u201360.","journal-title":"Oncogene"},{"key":"5_CR43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/viro.1999.0166","volume":"268","author":"M. Ikeda","year":"2000","unstructured":"Ikeda, M., A. Ikeda, L. C. Longan, and R. Longnecker. 2000. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. Virology 268:178\u201391.","journal-title":"Virology"},{"key":"5_CR44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/intimm\/11.1.81","volume":"11","author":"T. Imai","year":"1999","unstructured":"Imai, T., M. Nagira, S. Takagi, M. Kakizaki, M. Nishimura, et al. 1999. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11:81\u20138.","journal-title":"Int Immunol"},{"issue":"9","key":"5_CR45","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1099\/0022-1317-76-9-2141","volume":"76","author":"G. J. Inman","year":"1995","unstructured":"Inman, G. J., and P. J. Farrell. 1995. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays. J Gen Virol 76(Pt 9):2141\u20139.","journal-title":"J Gen Virol"},{"key":"5_CR46","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1128\/JVI.68.7.4369-4376.1994","volume":"68","author":"K. M. Izumi","year":"1994","unstructured":"Izumi, K. M., K. M. Kaye, and E. D. Kieff. 1994. Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation. J Virol 68:4369\u201376.","journal-title":"J Virol"},{"key":"5_CR47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0014-4827(91)90438-Z","volume":"197","author":"W. Q. Jiang","year":"1991","unstructured":"Jiang, W. Q., L. Szekely, V. Wendel-Hansen, N. Ringertz, G. Klein, and A. Rosen. 1991. Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. Exp Cell Res 197:314\u20138.","journal-title":"Exp Cell Res"},{"key":"5_CR48","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1128\/JVI.78.8.3984-3993.2004","volume":"78","author":"M. Kanamori","year":"2004","unstructured":"Kanamori, M., S. Watanabe, R. Honma, M. Kuroda, S. Imai, et al. 2004. Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells. J Virol 78:3984\u201393.","journal-title":"J Virol"},{"key":"5_CR49","doi-asserted-by":"crossref","first-page":"10104","DOI":"10.1128\/JVI.74.21.10104-10111.2000","volume":"74","author":"Y. Kawaguchi","year":"2000","unstructured":"Kawaguchi, Y., K. Nakajima, M. Igarashi, T. Morita, M. Tanaka, et al. 2000. Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: Implication of cytoplasmic function of EBNA-LP. J Virol 74:10104\u201311.","journal-title":"J Virol"},{"key":"5_CR50","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","volume":"90","author":"K. M. Kaye","year":"1993","unstructured":"Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 90:9150\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR51","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1128\/JVI.73.12.10525-10530.1999","volume":"73","author":"K. M. Kaye","year":"1999","unstructured":"Kaye, K. M., K. M. Izumi, H. Li, E. Johannsen, D. Davidson, et al. 1999. An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation. J Virol 73:10525\u201330.","journal-title":"J Virol"},{"key":"5_CR52","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/JVI.69.2.675-683.1995","volume":"69","author":"K. M. Kaye","year":"1995","unstructured":"Kaye, K. M., K. M. Izumi, G. Mosialos, and E. Kieff. 1995. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol 69:675\u201383.","journal-title":"J Virol"},{"key":"5_CR53","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1128\/JVI.79.16.10709-10717.2005","volume":"79","author":"G. L. Kelly","year":"2005","unstructured":"Kelly, G. L., A. E. Milner, R. J. Tierney, D. S. Croom-Carter, M. Altmann, et al. 2005. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J Virol 79:10709\u201317.","journal-title":"J Virol"},{"key":"5_CR54","first-page":"463","volume-title":"EBNA2 and notch signaling","author":"B. Kempkes","year":"2005","unstructured":"Kempkes, B., L. J. Strobl, G. W. Bornkamm, and U. Zimber-Strobl. 2005. EBNA2 and notch signaling. Norfolk: Caister Academic Press, pp. 463\u201399."},{"key":"5_CR55","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/emboj\/18.9.2511","volume":"18","author":"A. Kieser","year":"1999","unstructured":"Kieser, A., C. Kaiser, and W. Hammerschmidt. 1999. LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2. Embo J 18:2511\u201321.","journal-title":"Embo J"},{"key":"5_CR56","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/JVI.69.2.1280-1283.1995","volume":"69","author":"A. L. Kirchmaier","year":"1995","unstructured":"Kirchmaier, A. L., and B. Sugden. 1995. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus. J Virol 69:1280\u20133.","journal-title":"J Virol"},{"key":"5_CR57","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1093\/emboj\/19.24.6742","volume":"19","author":"N. Kitagawa","year":"2000","unstructured":"Kitagawa, N., M. Goto, K. Kurozumi, S. Maruo, M. Fukayama, et al. 2000. Epstein-Barr virus-encoded poly (A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. Embo J 19:6742\u201350.","journal-title":"Embo J"},{"key":"5_CR58","doi-asserted-by":"crossref","first-page":"7885","DOI":"10.1128\/JVI.70.11.7885-7893.1996","volume":"70","author":"M. K. Kitay","year":"1996","unstructured":"Kitay, M. K., and D. T. Rowe. 1996. Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP. J Virol 70:7885\u201393.","journal-title":"J Virol"},{"key":"5_CR59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/viro.1996.0289","volume":"220","author":"M. K. Kitay","year":"1996","unstructured":"Kitay, M. K., and D. T. Rowe. 1996. Protein\u2013protein interactions between Epstein-Barr virus nuclear antigen-LP and cellular gene products: Binding of 70-kilodalton heat shock proteins. Virology 220:91\u20139.","journal-title":"Virology"},{"key":"5_CR60","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1128\/JVI.77.7.4261-4272.2003","volume":"77","author":"J. S. Knight","year":"2003","unstructured":"Knight, J. S., K. Lan, C. Subramanian, and E. S. Robertson. 2003. Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. J Virol 77:4261\u201372.","journal-title":"J Virol"},{"key":"5_CR61","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1128\/JVI.78.4.1981-1991.2004","volume":"78","author":"J. S. Knight","year":"2004","unstructured":"Knight, J. S., and E. S. Robertson. 2004. Epstein-Barr virus nuclear antigen 3C regulates cyclin A\/p27 complexes and enhances cyclin A-dependent kinase activity. J Virol 78:1981\u201391.","journal-title":"J Virol"},{"key":"5_CR62","doi-asserted-by":"crossref","first-page":"12857","DOI":"10.1128\/JVI.78.23.12857-12867.2004","volume":"78","author":"J. S. Knight","year":"2004","unstructured":"Knight, J. S., N. Sharma, D. E. Kalman, and E. S. Robertson. 2004. A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells. J Virol 78:12857\u201367.","journal-title":"J Virol"},{"key":"5_CR63","doi-asserted-by":"crossref","first-page":"18562","DOI":"10.1073\/pnas.0503886102","volume":"102","author":"J. S. Knight","year":"2005","unstructured":"Knight, J. S., N. Sharma, and E. S. Robertson. 2005. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc Natl Acad Sci USA 102:18562\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR64","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1128\/MCB.25.5.1749-1763.2005","volume":"25","author":"J. S. Knight","year":"2005","unstructured":"Knight, J. S., N. Sharma, and E. S. Robertson. 2005. SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen. Mol Cell Biol 25:1749\u201363.","journal-title":"Mol Cell Biol"},{"key":"5_CR65","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1128\/JVI.64.6.2530-2536.1990","volume":"64","author":"J. C. Knutson","year":"1990","unstructured":"Knutson, J. C. 1990. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization. J Virol 64:2530\u20136.","journal-title":"J Virol"},{"key":"5_CR66","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1099\/0022-1317-44-2-573","volume":"44","author":"S. I. Koliais","year":"1979","unstructured":"Koliais, S. I. 1979. Mode of integration of Epstein-Barr virus genome into host DNA in Burkitt lymphoma cells. J Gen Virol 44:573\u20136.","journal-title":"J Gen Virol"},{"key":"5_CR67","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","volume":"79","author":"L. L. Laichalk","year":"2005","unstructured":"Laichalk, L. L., and D. A. Thorley-Lawson. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79:1296\u2013307.","journal-title":"J Virol"},{"key":"5_CR68","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1002\/j.1460-2075.1994.tb06900.x","volume":"13","author":"G. Laux","year":"1994","unstructured":"Laux, G., B. Adam, L. J. Strobl, and F. Moreau-Gachelin. 1994. The Spi-1\/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. Embo J 13:5624\u201332.","journal-title":"Embo J"},{"key":"5_CR69","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/j.1460-2075.1988.tb02874.x","volume":"7","author":"G. Laux","year":"1988","unstructured":"Laux, G., M. Perricaudet, and P. J. Farrell. 1988. A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. Embo J 7:769\u201374.","journal-title":"Embo J"},{"key":"5_CR70","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1128\/JVI.73.4.2974-2982.1999","volume":"73","author":"M. A. Lee","year":"1999","unstructured":"Lee, M. A., M. E. Diamond, and J. L. Yates. 1999. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus. J Virol 73:2974\u201382.","journal-title":"J Virol"},{"key":"5_CR71","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1073\/pnas.78.2.805","volume":"78","author":"M. R. Lerner","year":"1981","unstructured":"Lerner, M. R., N. C. Andrews, G. Miller, and J. A. Steitz. 1981. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 78:805\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR72","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","volume":"94","author":"J. Levitskaya","year":"1997","unstructured":"Levitskaya, J., A. Sharipo, A. Leonchiks, A. Ciechanover, and M. G. Masucci. 1997. Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 94:12616\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR73","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/JVI.58.1.233-237.1986","volume":"58","author":"D. Liebowitz","year":"1986","unstructured":"Liebowitz, D., D. Wang, and E. Kieff. 1986. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J Virol 58:233\u20137.","journal-title":"J Virol"},{"key":"5_CR74","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1073\/pnas.90.20.9237","volume":"90","author":"P. D. Ling","year":"1993","unstructured":"Ling, P. D., D. R. Rawlins, and S. D. Hayward. 1993. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc Natl Acad Sci USA 90:9237\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR75","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0042-6822(03)00145-4","volume":"310","author":"P. Liu","year":"2003","unstructured":"Liu, P., and S. H. Speck. 2003. Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta. Virology 310:199\u2013206.","journal-title":"Virology"},{"key":"5_CR76","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1128\/JVI.64.5.2319-2326.1990","volume":"64","author":"R. Longnecker","year":"1990","unstructured":"Longnecker, R., and E. Kieff. 1990. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J Virol 64:2319\u201326.","journal-title":"J Virol"},{"key":"5_CR77","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.virol.2005.09.064","volume":"345","author":"C. C. Lu","year":"2006","unstructured":"Lu, C. C., Y. Y. Jeng, C. H. Tsai, M. Y. Liu, S. W. Yeh, et al. 2006. Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus. Virology 345:358\u201372.","journal-title":"Virology"},{"key":"5_CR78","doi-asserted-by":"crossref","first-page":"29873","DOI":"10.1074\/jbc.272.47.29873","volume":"272","author":"D. Mackey","year":"1997","unstructured":"Mackey, D., and B. Sugden. 1997. Studies on the mechanism of DNA linking by Epstein-Barr virus nuclear antigen 1. J Biol Chem 272:29873\u20139.","journal-title":"J Biol Chem"},{"key":"5_CR79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01316882","volume":"129","author":"M. Marschall","year":"1993","unstructured":"Marschall, M., P. Alliger, F. Schwarzmann, C. Bogedain, M. Brand, et al. 1993. The lytic transition of Epstein-Barr virus is imitated by recombinant B-cells. Arch Virol 129:23\u201333.","journal-title":"Arch Virol"},{"key":"5_CR80","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1128\/JVI.76.13.6460-6472.2002","volume":"76","author":"E. Masy","year":"2002","unstructured":"Masy, E., E. Adriaenssens, C. Montpellier, P. Crepieux, A. Mougel, et al. 2002. Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation. J Virol 76:6460\u201372.","journal-title":"J Virol"},{"key":"5_CR81","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/342934a0","volume":"342","author":"N. Matsunami","year":"1989","unstructured":"Matsunami, N., Y. Hamaguchi, Y. Yamamoto, K. Kuze, K. Kangawa, et al. 1989. A protein binding to the J kappa recombination sequence of immunoglobulin genes contains a sequence related to the integrase motif. Nature 342:934\u20137.","journal-title":"Nature"},{"key":"5_CR82","first-page":"205","volume":"62","author":"G. Miller","year":"1989","unstructured":"Miller, G. 1989. The switch between EBV latency and replication. Yale J Biol Med 62:205\u201313.","journal-title":"Yale J Biol Med"},{"key":"5_CR83","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/JVI.71.1.586-594.1997","volume":"71","author":"W. E. Miller","year":"1997","unstructured":"Miller, W. E., G. Mosialos, E. Kieff, and N. Raab-Traub. 1997. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation. J Virol 71:586\u201394.","journal-title":"J Virol"},{"key":"5_CR84","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1128\/JVI.64.2.829-837.1990","volume":"64","author":"R. Moorthy","year":"1990","unstructured":"Moorthy, R., and D. A. Thorley-Lawson. 1990. Processing of the Epstein-Barr virus-encoded latent membrane protein p63\/LMP. J Virol 64:829\u201337.","journal-title":"J Virol"},{"key":"5_CR85","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","volume":"80","author":"G. Mosialos","year":"1995","unstructured":"Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389\u201399.","journal-title":"Cell"},{"key":"5_CR86","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.2000.0602","volume":"277","author":"M. Murakami","year":"2000","unstructured":"Murakami, M., Y. Hoshikawa, Y. Satoh, H. Ito, M. Tajima, et al. 2000. Tumorigenesis of Epstein-Barr virus-positive epithelial cell lines derived from gastric tissues in the SCID mouse. Virology 277:20\u20136.","journal-title":"Virology"},{"key":"5_CR87","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1128\/JVI.79.3.1559-1568.2005","volume":"79","author":"M. Murakami","year":"2005","unstructured":"Murakami, M., K. Lan, C. Subramanian, and E. S. Robertson. 2005. Epstein-Barr virus nuclear antigen 1 interacts with Nm23\u2013H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J Virol 79:1559\u201368.","journal-title":"J Virol"},{"key":"5_CR88","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/emboj\/21.5.954","volume":"21","author":"A. Nanbo","year":"2002","unstructured":"Nanbo, A., K. Inoue, K. Adachi-Takasawa, and K. Takada. 2002. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. Embo J 21:954\u201365.","journal-title":"Embo J"},{"key":"5_CR89","doi-asserted-by":"crossref","first-page":"12280","DOI":"10.1128\/JVI.79.19.12280-12285.2005","volume":"79","author":"A. Nanbo","year":"2005","unstructured":"Nanbo, A., H. Yoshiyama, and K. Takada. 2005. Epstein-Barr virus-encoded poly(A)- RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells. J Virol 79:12280\u20135.","journal-title":"J Virol"},{"key":"5_CR90","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0042-6822(90)90027-O","volume":"176","author":"L. Petti","year":"1990","unstructured":"Petti, L., C. Sample, and E. Kieff. 1990. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins. Virology 176:563\u201374.","journal-title":"Virology"},{"key":"5_CR91","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1128\/JVI.71.11.8552-8562.1997","volume":"71","author":"S. A. Radkov","year":"1997","unstructured":"Radkov, S. A., M. Bain, P. J. Farrell, M. West, M. Rowe, and M. J. Allday. 1997. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. J Virol 71:8552\u201362.","journal-title":"J Virol"},{"key":"5_CR92","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/338383b0","volume":"338","author":"M. Reth","year":"1989","unstructured":"Reth, M. 1989. Antigen receptor tail clue. Nature 338:383\u20134.","journal-title":"Nature"},{"key":"5_CR93","volume-title":"Fields virology","author":"A. Rickinson","year":"2001","unstructured":"Rickinson, A., and E. Kieff. 2001. Fields virology. Philadelphia: Lippincott Williams & Wilkins Publishers, pp. 2575\u2013627."},{"key":"5_CR94","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.69.5.3108-3116.1995","volume":"69","author":"E. S. Robertson","year":"1995","unstructured":"Robertson, E. S., S. Grossman, E. Johannsen, C. Miller, J. Lin, et al. 1995. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol 69:3108\u201316.","journal-title":"J Virol"},{"key":"5_CR95","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1128\/JVI.70.5.3068-3074.1996","volume":"70","author":"E. S. Robertson","year":"1996","unstructured":"Robertson, E. S., J. Lin, and E. Kieff. 1996. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J Virol 70:3068\u201374.","journal-title":"J Virol"},{"key":"5_CR96","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1128\/JVI.68.3.1449-1458.1994","volume":"68","author":"E. S. Robertson","year":"1994","unstructured":"Robertson, E. S., B. Tomkinson, and E. Kieff. 1994. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro. J Virol 68:1449\u201358.","journal-title":"J Virol"},{"key":"5_CR97","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1128\/JVI.63.4.1531-1539.1989","volume":"63","author":"C. Rooney","year":"1989","unstructured":"Rooney, C., J. G. Howe, S. H. Speck, and G. Miller. 1989. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. J Virol 63:1531\u20139.","journal-title":"J Virol"},{"key":"5_CR98","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1128\/JVI.63.7.3109-3116.1989","volume":"63","author":"C. M. Rooney","year":"1989","unstructured":"Rooney, C. M., D. T. Rowe, T. Ragot, and P. J. Farrell. 1989. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol 63:3109\u201316.","journal-title":"J Virol"},{"key":"5_CR99","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1128\/JVI.72.7.6034-6039.1998","volume":"72","author":"T. Sakai","year":"1998","unstructured":"Sakai, T., Y. Taniguchi, K. Tamura, S. Minoguchi, T. Fukuhara, et al. 1998. Functional replacement of the intracellular region of the Notch1 receptor by Epstein-Barr virus nuclear antigen 2. J Virol 72:6034\u20139.","journal-title":"J Virol"},{"key":"5_CR100","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.66.8.4654-4661.1992","volume":"66","author":"J. Sample","year":"1992","unstructured":"Sample, J., E. B. Henson, and C. Sample. 1992. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol 66:4654\u201361.","journal-title":"J Virol"},{"key":"5_CR101","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1073\/pnas.83.14.5096","volume":"83","author":"J. Sample","year":"1986","unstructured":"Sample, J., M. Hummel, D. Braun, M. Birkenbach, and E. Kieff. 1986. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: A probable transcriptional initiation site. Proc Natl Acad Sci USA 83:5096\u2013100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR102","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/JVI.63.2.933-937.1989","volume":"63","author":"J. Sample","year":"1989","unstructured":"Sample, J., D. Liebowitz, and E. Kieff. 1989. Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J Virol 63:933\u20137.","journal-title":"J Virol"},{"key":"5_CR103","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/JVI.67.5.2853-2861.1993","volume":"67","author":"G. Scala","year":"1993","unstructured":"Scala, G., I. Quinto, M. R. Ruocco, M. Mallardo, C. Ambrosino, et al. 1993. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J Virol 67:2853\u201361.","journal-title":"J Virol"},{"key":"5_CR104","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1093\/emboj\/20.16.4588","volume":"20","author":"A. Schepers","year":"2001","unstructured":"Schepers, A., M. Ritzi, K. Bousset, E. Kremmer, J. L.Yates, et al. 2001. Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. Embo J 20:4588\u2013602.","journal-title":"Embo J"},{"key":"5_CR105","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1073\/pnas.82.13.4321","volume":"82","author":"R. J. Schneider","year":"1985","unstructured":"Schneider, R. J., B. Safer, S. M. Munemitsu, C. E. Samuel, and T. Shenk. 1985. Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2 alpha subunit subsequent to infection. Proc Natl Acad Sci USA 82:4321\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR106","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1128\/JVI.67.6.3240-3245.1993","volume":"67","author":"N. Shimizu","year":"1993","unstructured":"Shimizu, N., and K. Takada. 1993. Analysis of the BZLF1 promoter of Epstein-Barr virus: Identification of an anti-immunoglobulin response sequence. J Virol 67:3240\u20135.","journal-title":"J Virol"},{"key":"5_CR107","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1128\/JVI.68.9.6069-6073.1994","volume":"68","author":"N. Shimizu","year":"1994","unstructured":"Shimizu, N., A. Tanabe-Tochikura, Y. Kuroiwa, and K. Takada. 1994. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: Malignant phenotypes of BL cells are dependent on EBV. J Virol 68:6069\u201373.","journal-title":"J Virol"},{"key":"5_CR108","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1002\/j.1460-2075.1994.tb06634.x","volume":"13","author":"A. J. Sinclair","year":"1994","unstructured":"Sinclair, A. J., I. Palmero, G. Peters, and P. J. Farrell. 1994. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. Embo J 13:3321\u20138.","journal-title":"Embo J"},{"key":"5_CR109","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/scbi.2001.0414","volume":"11","author":"P. Smith","year":"2001","unstructured":"Smith, P. 2001. Epstein-Barr virus complementary strand transcripts (CSTs\/BARTs) and cancer. Semin Cancer Biol 11:469\u201376.","journal-title":"Semin Cancer Biol"},{"key":"5_CR110","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1002\/j.1460-2075.1994.tb06810.x","volume":"13","author":"D. K. Snudden","year":"1994","unstructured":"Snudden, D. K., J. Hearing, P. R. Smith, F. A. Grasser, and B. E. Griffin. 1994. EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles \u2018RGG\u2019 RNA binding proteins. Embo J 13:4840\u20137.","journal-title":"Embo J"},{"key":"5_CR111","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0966-842X(97)01129-3","volume":"5","author":"S. H. Speck","year":"1997","unstructured":"Speck, S. H., T. Chatila, and E. Flemington. 1997. Reactivation of Epstein-Barr virus: Regulation and function of the BZLF1 gene. Trends Microbiol 5:399\u2013405.","journal-title":"Trends Microbiol"},{"key":"5_CR112","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/JVI.74.4.1727-1735.2000","volume":"74","author":"L. J. Strobl","year":"2000","unstructured":"Strobl, L. J., H. Hofelmayr, G. Marschall, M. Brielmeier, G. W. Bornkamm, and U. Zimber-Strobl. 2000. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J Virol 74:1727\u201335.","journal-title":"J Virol"},{"key":"5_CR113","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1128\/JVI.76.10.4699-4708.2002","volume":"76","author":"C. Subramanian","year":"2002","unstructured":"Subramanian, C., S. Hasan, M. Rowe, M. Hottiger, R. Orre, and E. S. Robertson. 2002. Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3\/HAT domains and cooperate in regulation of transcription and histone acetylation. J Virol 76:4699\u2013708.","journal-title":"J Virol"},{"key":"5_CR114","first-page":"402","volume":"27","author":"L. J. Swinnen","year":"2000","unstructured":"Swinnen, L. J. 2000. Transplantation-related lymphoproliferative disorder: A model for human immunodeficiency virus-related lymphomas. Semin Oncol 27:402\u20138.","journal-title":"Semin Oncol"},{"key":"5_CR115","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1128\/JVI.73.6.5064-5069.1999","volume":"73","author":"A. Szeles","year":"1999","unstructured":"Szeles, A., K. I. Falk, S. Imreh, and G. Klein. 1999. Visualization of alternative Epstein-Barr virus expression programs by fluorescent in situ hybridization at the cell level. J Virol 73:5064\u20139.","journal-title":"J Virol"},{"key":"5_CR116","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ijc.2910330106","volume":"33","author":"K. Takada","year":"1984","unstructured":"Takada, K. 1984. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33:27\u201332.","journal-title":"Int J Cancer"},{"key":"5_CR117","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/scbi.2001.0413","volume":"11","author":"K. Takada","year":"2001","unstructured":"Takada, K., and A. Nanbo. 2001. The role of EBERs in oncogenesis. Semin Cancer Biol 11:461\u20137.","journal-title":"Semin Cancer Biol"},{"key":"5_CR118","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/S0960-9822(95)00279-X","volume":"5","author":"K. Tamura","year":"1995","unstructured":"Tamura, K., Y. Taniguchi, S. Minoguchi, T. Sakai, T. Tun, et al. 1995. Physical interaction between a novel domain of the receptor notch and the transcription factor RBP-J kappa\/Su(H). Curr Biol 5:1416\u201323.","journal-title":"Curr Biol"},{"key":"5_CR119","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1073\/pnas.91.8.3463","volume":"91","author":"D. P. Toczyski","year":"1994","unstructured":"Toczyski, D. P., A. G. Matera, D. C. Ward, and J. A. Steitz. 1994. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proc Natl Acad Sci USA 91:3463\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR120","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/08830180109045584","volume":"20","author":"T. Tsubata","year":"2001","unstructured":"Tsubata, T., and J. Wienands. 2001. B cell signaling. Introduction. Int Rev Immunol 20:675\u20138.","journal-title":"Int Rev Immunol"},{"key":"5_CR121","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/JVI.64.5.2309-2318.1990","volume":"64","author":"F. Wang","year":"1990","unstructured":"Wang, F., C. Gregory, C. Sample, M. Rowe, D. Liebowitz, et al. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 64:2309\u201318.","journal-title":"J Virol"},{"key":"5_CR122","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1073\/pnas.84.10.3452","volume":"84","author":"F. Wang","year":"1987","unstructured":"Wang, F., C. D. Gregory, M. Rowe, A. B. Rickinson, D. Wang, et al. 1987. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc Natl Acad Sci USA 84:3452\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR123","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1128\/JVI.64.7.3407-3416.1990","volume":"64","author":"F. Wang","year":"1990","unstructured":"Wang, F., S. F. Tsang, M. G. Kurilla, J. I. Cohen, and E. Kieff. 1990. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol 64:3407\u201316.","journal-title":"J Virol"},{"key":"5_CR124","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/j.1460-2075.1996.tb00674.x","volume":"15","author":"J. B. Wilson","year":"1996","unstructured":"Wilson, J. B., J. L. Bell, and A. J. Levine. 1996. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. Embo J 15:3117\u201326.","journal-title":"Embo J"},{"key":"5_CR125","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1073\/pnas.87.5.1725","volume":"87","author":"M. Woisetschlaeger","year":"1990","unstructured":"Woisetschlaeger, M., C. N. Yandava, L. A. Furmanski, J. L. Strominger, and S. H. Speck. 1990. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci USA 87:1725\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR126","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1128\/jvi.76.5.2480-2490.2002","volume":"76","author":"H. Wu","year":"2002","unstructured":"Wu, H., P. Kapoor, and L. Frappier. 2002. Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J Virol 76:2480\u201390.","journal-title":"J Virol"},{"key":"5_CR127","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1006\/viro.1994.1578","volume":"204","author":"R. Yalamanchili","year":"1994","unstructured":"Yalamanchili, R., X. Tong, S. Grossman, E. Johannsen, G. Mosialos, and E. Kieff. 1994. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Virology 204:634\u201341.","journal-title":"Virology"},{"key":"5_CR128","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1073\/pnas.81.12.3806","volume":"81","author":"J. Yates","year":"1984","unstructured":"Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 81:3806\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR129","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1128\/JVI.74.10.4512-4522.2000","volume":"74","author":"J. L. Yates","year":"2000","unstructured":"Yates, J. L., S. M. Camiolo, and J. M. Bashaw. 2000. The minimal replicator of Epstein-Barr virus oriP. J Virol 74:4512\u201322.","journal-title":"J Virol"},{"key":"5_CR130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/JVI.65.1.483-488.1991","volume":"65","author":"J. L. Yates","year":"1991","unstructured":"Yates, J. L., and N. Guan. 1991. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J Virol 65:483\u20138.","journal-title":"J Virol"},{"key":"5_CR131","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/313812a0","volume":"313","author":"J. L. Yates","year":"1985","unstructured":"Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812\u20135.","journal-title":"Nature"},{"key":"5_CR132","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","volume":"22","author":"L. S. Young","year":"2003","unstructured":"Young, L. S., and P. G. Murray. 2003. Epstein-Barr virus and oncogenesis: From latent genes to tumours. Oncogene 22:5108\u201321.","journal-title":"Oncogene"},{"key":"5_CR133","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"L. S. Young","year":"2004","unstructured":"Young, L. S., and A. B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757\u201368.","journal-title":"Nat Rev Cancer"},{"key":"5_CR134","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/JVI.80.5.2548-2565.2006","volume":"80","author":"J. Yuan","year":"2006","unstructured":"Yuan, J., E. Cahir-McFarland, B. Zhao, and E. Kieff. 2006. Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol 80:2548\u201365.","journal-title":"J Virol"},{"issue":"3","key":"5_CR135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1099\/0022-1317-74-3-509","volume":"74","author":"C. X. Zhang","year":"1993","unstructured":"Zhang, C. X., P. Lowrey, S. Finerty, and A. J. Morgan. 1993. Analysis of Epstein-Barr virus gene transcription in lymphoma induced by the virus in the cottontop tamarin by construction of a cDNA library with RNA extracted from a tumour biopsy. J Gen Virol 74(Pt 3):509\u201314.","journal-title":"J Gen Virol"},{"key":"5_CR136","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/JVI.75.6.2946-2956.2001","volume":"75","author":"J. Zhang","year":"2001","unstructured":"Zhang, J., H. Chen, G. Weinmaster, and S. D. Hayward. 2001. Epstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC. J Virol 75:2946\u201356.","journal-title":"J Virol"},{"key":"5_CR137","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1128\/JVI.74.11.5151-5160.2000","volume":"74","author":"B. Zhao","year":"2000","unstructured":"Zhao, B., and C. E. Sample. 2000. Epstein-Barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1\/Spi-B binding site. J Virol 74:5151\u201360.","journal-title":"J Virol"},{"key":"5_CR138","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/j.1460-2075.1993.tb05642.x","volume":"12","author":"U. Zimber-Strobl","year":"1993","unstructured":"Zimber-Strobl, U., E. Kremmer, F. Grasser, G. Marschall, G. Laux, and G. W. Bornkamm. 1993. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. Embo J 12:167\u201375.","journal-title":"Embo J"},{"key":"5_CR139","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JVI.65.1.415-423.1991","volume":"65","author":"U. Zimber-Strobl","year":"1991","unstructured":"Zimber-Strobl, U., K. O. Suentzenich, G. Laux, D. Eick, M. Cordier, et al. 1991. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J Virol 65:415\u201323.","journal-title":"J Virol"}],"container-title":["Cancer Treatment and Research","Aids-Associated Viral Oncogenesis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-0-387-46816-7_5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T16:58:41Z","timestamp":1605632321000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-0-387-46816-7_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"ISBN":["9780387468044","9780387468167"],"references-count":139,"URL":"https:\/\/doi.org\/10.1007\/978-0-387-46816-7_5","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-0-387-46816-7","asserted-by":"object"}]},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2007]]}}}